@Injective just saw a surge in attention while the broader market bleeds red.
Is it the recent EVM integration rollout or large players positioning?
Hard to say — but I’m not complaining 😅
Would love to hear any thoughts.
Is it the recent EVM integration rollout or large players positioning?
Hard to say — but I’m not complaining 😅
Would love to hear any thoughts.